Hepatobiliary Surgery and Nutrition

Article	Citations
Reply to: The letter to the editor “More details are needed about the use of multicenter propensity score matching analysis” by Feng et al.	137
Can we talk about “futile surgery” for the upfront treatment of the perihilar cholangiocarcinoma?	79
Neoadjuvant therapy for resectable pancreatic cancers	79
Futibatinib: new targeted therapy in intrahepatic cholangiocarcinoma	63
Managing portal hypertension in patients with liver cirrhosis and hepatocellular carcinoma: non-invasive diagnosis and systemic treatment considerations	59
Acute coil migration in upper gastrointestinal bleeding	41
Heterogeneity in the risk of incident liver cirrhosis driven by PNPLA3 genotype and diabetes among different populations	40
Prospective evaluation of 18F-FDG positron emission tomography in the preoperative staging of patients with hepatic colorectal metastases	39
The limits of segmental dichotomy: rethinking how we classify and compare minimally invasive liver resections	39
Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society Consensus Conference: towards better clinical care in transplant hepatology	37
Does a patient who needs portal vein embolization (PVE) to proceed to major hepatectomy (MH) have the same hepatic functional reserve than a patient with no preoperative PVE?	34
Assessment of long-term graft function following total pancreatectomy and autologous islet transplantation: the Leicester experience	30
The application of real-time indocyanine green fluorescence cholangiography in laparoscopic living donor left lateral sectionectomy	27
Single-port robotic pancreaticoduodenectomy with the SHURUI snake-arm system: first clinical application	27
Evidence-based strategies of exercise and nutrition in sarcopenia care in liver cirrhosis patients	27
Preoperative assessment of liver function and perioperative management of posthepatectomy liver failure	24
Review of practice informing data and current state of NCCN consensus guidelines in hepatobiliary cancers	23
Nonalcoholic steatohepatitis critically rewires the ischemia/reperfusion-induced dysregulation of cardiolipins and sphingolipids in mice	22
Impact of expert centers annual case volume on outcomes of minimally-invasive liver resections: international multicenter study	21
Technical performance, surgical workload and patient outcomes of robotic and laparoscopic surgery for pediatric choledochal cyst: a multicenter retrospective cohort and propensity score-matched study	20
A 7-year-old girl with giant congenital biliary dilatation	20
Comment on: “Liver transplantation for iatrogenic bile duct injury during cholecystectomy: a French retrospective multicenter study”	18
Reply to the commentary on “The efficiency of pathological response after preoperative transcatheter arterial chemoembolization for microvascular invasion and early tumor recurrence in hepatocellular	18
Addressing the malnutrition gap requires high-quality research, recognition of intervention complexity, and equitable implementation strategies	18
Evolocumab induced short-term biliary stent blockage and acute cholangitis in a jaundice patient with pancreatic carcinoma: a rare complication of PCSK9 inhibitor	17

Enhancing diagnostic strategies for biliary strictures: an evolving landscape	16
Liver transplantation for hepatocellular carcinoma arising in non-cirrhotic liver: a national-wide retrospective cohort study with propensity score matching analysis in China	16
Robotic hepatectomy: challenge and progression	16
The Society for Immunotherapy of Cancer clinical practice guideline on immunotherapy for hepatocellular carcinoma	15
The role of resection margin status on recurrence and selection of patients for adjuvant radiotherapy in distal cholangiocarcinoma	15
Construction and application of multicellular tumor microenvironment models based on three-dimensional bioprinting technology	15
Dietitians’ role in obesity care: insights from the Academy of Nutrition and Dietetics	14
Performance of major liver resection for gallbladder cancer—a western retrospective single center cohort study	14
Innovations in liver organoids: the role of 3D bioprinting in creating functional organoids	14
Guidelines for the management of pancreatic cystic lesions: many options, too few solutions?	14
Expert consensus on difficult airway assessment	14
Rethinking resectability: the case for neoadjuvant treatment in resectable pancreatic cancer	14
Convergent bioprinting and microfluidics: toward next-generation biomimetic tumor models	13
Outcomes after surgery for locally advanced pancreatic cancer compared to borderline and upfront resectable pancreatic cancer	13
A proposal to simplify the definition of metabolic dysfunction-associated steatotic liver disease in youths	13
Does preoperative routine statin use reduce post-hepatectomy liver failure?—an international multicentre retrospective cohort study on 2,342 patients	12
“One-day, one-stay, and one-step” lessons from the Danish guidelines for the treatment of gallstone disease	12
Propensity score matching study of 325 patients with spontaneous rupture of hepatocellular carcinoma	12
Understanding drug-induced liver injury from the perspective of traditional Chinese medicine theory—Huohou theory of traditional Chinese medicine	11
How to improve the care of decompensated cirrhosis: the intervention model for chronic disease management	11
Novel biomarkers for hepatocellular carcinoma detection and treatment	11
Perioperative management of patients with liver cancer complicated with sarcopenia	11
Combination therapies for advanced hepatocellular carcinoma: a beacon of light or a castle in the air	10
Trimming the fat myth: adipose tissue’s role in liver regeneration	10
Impact of donor-recipient sex-matching patterns on liver transplantation outcomes: a cohort study based on United Network of Organ Sharing data	10
Construction of an intrahepatic portosystemic shunt using the magnetic compression technique: preliminary experiments in a canine model	10
The ESSENCE of hope: what semaglutide’s Food and Drug Administration approval means for metabolic dysfunction-associated steatohepatitis	10
Should all patients be offered liver venous deprivation for insufficient future liver remnant hypertrophy prior to major hepatectomy?	10
Clinical outcomes of hepatectomy after partial response to immune checkpoint inhibitor-based combination therapy in patients with extrahepatic hepatocellular carcinoma metastasis	10
Resection and yttrium-90 radioembolization as sequential downstaging to living donor liver transplantation for large, multifocal hepatocellular carcinoma with lobar portal vein tumor thrombosis	10
Laparoscopic partial splenectomy in the treatment of splenic ectopic pregnancy	9
Deceased donor liver transplant outcomes: does donor drinking matter?	9
Thermal ablation in the curative treatment of colorectal liver metastasis: new standard of care?—lessons learned from the COLLISION trial	9
Highlights of constructing liver-relevant in vitro models with 3D bioprinting	9
Body fat distribution: a crucial target for intervention in nonalcoholic fatty liver disease and fibrosis	9
Association of a novel glycemic control index, time in range, with infectious complications after pancreatectomy	9
Practice guidance documents for the diagnosis and management of non-alcoholic fatty liver disease—recent updates and open questions	9
Minimally invasive hepatectomy is here to stay, but more evidence is needed	8
“Winning” with laparoscopic liver resection for colorectal cancer liver metastases (CRLM)	8
ALPPS versus portal vein embolization for hepatitis B virus-associated hepatocellular carcinoma: a delicate balance between volume and morbidity	8
Validation of the Institute Mutualiste Montsouris system for the stratification of laparoscopic liver resections: an international multicenter study	8
Pushing to resect colorectal liver metastases: rethinking surgical strategy in colorectal liver metastases with extrahepatic spread	8
De-escalating local therapies without compromising outcomes: lessons from the COLLISION trial	8
Confounders in developing a machine learning model for colorectal liver metastasis post-hepatectomy prognostications	8
Never change a winning team—liver stiffness measurement and platelet count as key surrogates for clinically significant portal hypertension	8
Development of scoring models to predict early pancreatic cancer risk in new-onset diabetes mellitus patients	8
Robotic-assisted hepatopancreatoduodenectomy and resection of pancreatic tail for one multiple endocrine neoplasia type 1 secreting multiple hormones	8
Liver transplantation for perihilar cholangiocarcinoma is not a provocative idea	8
Metabolic dysfunction-associated fatty liver disease and hepatocellular carcinoma: present and future	8
Prediction of postoperative early recurrence and response to adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma with microvascular invasion after hepatectomy: a multicenter	8

Application progress of spatial omics in hepatobiliary tumor research	8
Difficulties and opportunities of hospice care—the role of doctors	8
Targeted therapies in cholangiocarcinoma: light at the end of the tunnel?	8
Engineering the tumor microenvironment via 3D multicellular bioprinting for personalized immunotherapy assessment and resistance deciphering	8
Surgical resection for pancreatic ductal adenocarcinoma with liver metastasis: is this the beginning of a new era?	7
Risk predictors of post-hepatectomy liver failure: unraveling complexities and navigating challenges in clinical application	7
To drain or not to drain after distal pancreatectomy: reflexions on the PANDORINA trial	7
Serum metabolic effects of corn oligopeptides with 7-day supplementation on early post-surgery primary liver cancer patients: a double-blind randomized controlled trial	7
Feasibility and outcomes of robotic partial pancreatoduodenectomy	7
De-escalating surgical treatment in low stage gallbladder cancer	7
Comparative effectiveness of medical treatment vs. metabolic surgery for histologically proven non-alcoholic steatohepatitis and fibrosis: a matched network meta-analysis	7
Primary sclerosing cholangitis and cholangiocarcinoma: the 2023 practice guidance and future perspectives	7
Screening for pancreatic cancer in individuals with genetic susceptibility	7
Adjuvant atezolizumab-bevacizumab after curative therapy for hepatocellular carcinoma	7
Getting persuasive about the non-invasive: assessing liver fibrosis in practice—without a biopsy	7
Algorithm-based care for early recognition and management of complications after pancreatic resection: toward standardization of postoperative care	7
Alcohol-related liver disease	7
Novel preoperative strategies to improve hepatocellular carcinoma resectability	7
A puzzling mixed cystic-solid mass at the hepatic hilum	6
Eggplant-like pancreas: transformation in a year	6
A systematic review of methodology in nutritional trials in patients undergoing pancreatoduodenectomy	6
Ethical issues in innovative clinical research	6
Necessity of integrating statistical inference and clinical practice in developing clinical models: bias introduced by neoadjuvant chemotherapy	6
Non-invasive strategies to predict post-hepatectomy liver failure	6
Acute cholecystitis in older adults with multimorbidity: does surgery offer better outcomes?	6
Ectopic hepatocellular carcinoma of the abdominal wall	6
Advancements and challenges in robotic donor hepatectomy: current evidence and unresolved questions	6
Risk factors for non-alcoholic fatty liver disease delineate the battlegrounds in optimizing disease prevention	6
A new TNM T3 subclassification with corresponding prognostic stage grouping for gallbladder cancer: a multicenter retrospective study	6
Liver transplantation for non-resectable colorectal metastases—an evolving paradigm in transplant oncology	6
Nutritional management guidelines for pancreatitis—a commentary	6
Laparoscopic duodenum-preserving pancreatic head resection guided by the two-stage indocyanine green fluorescence imaging	6
Frailty assessed using the Liver Frailty IndexTM (LFI) is a risk factor for mortality in patients with advanced hepatocellular carcinoma treated with atezolizumab-bevacizumab	6
Evolution of systemic therapy for advanced-stage hepatocellular carcinoma	6
The lymphatic vessels of the liver observed by Frederik Ruysch	6
The role of FGFR inhibitors in the treatment of intrahepatic cholangiocarcinoma—unveiling the future challenges in drug therapy	6
Early bifurcation of hepatic artery in right-sided living-donor hepatectomy at Asan Medical Center: rarely a critical issue	6
Validation of the European Association for the Study of the Liver algorithm for the noninvasive diagnosis of advanced fibrosis in metabolic-dysfunction associated steatotic liver disease	6
ESMO 2023 pancreatic cancer guidelines signal stepwise progress	6
Decision-making in high-risk leakage duodenopancreatectomy: pancreatic anastomosis or total pancreatectomy?	5
Can artificial intelligence deliver on the promise of precision medicine?	5
Rethinking portal hypertension in hepatocellular carcinoma resection: a gradient of risk beyond black and white	5
The Hong Kong consensus recommendations on the diagnosis and management of pancreatic cystic lesions	5
EREG-secreting THBS1+ tissue monocytes are recruited by C5a to promote rapid liver regeneration in patients and mice during the ALPPS procedure	5
In situ liver resection under venovenous bypass (LR-VVB) or venoarterial bypass (LR-VAB) adjunct to total vascular exclusion (TVE) as extreme liver surgery	5
Can liver stiffness measurement accurately predict disease progression and clinical outcome in patients with metabolic dysfunction-associated steatotic liver disease and bridging fibrosis or cirrhosis	5
Advanced pancreatic neuroendocrine neoplasia (pNEN): complex diseases with therapeutic challenges	5
Endothelial glycocalyx damage marker syndecan-1 during hypothermic oxygenated machine perfusion of donor grafts facilitates prediction of early allograft dysfunction after liver transplantation	5
Molecular profiling and patient selection for the multimodal approaches for patients with resectable colorectal liver metastases	5
Surgical resection for hepatocellular carcinoma in cirrhotic patients with clinically significant portal hypertension: a multidisciplinary team decision	5
How will the latest modifications to the CG189 NICE guidelines for obesity management likely impact clinical care?	5
How to deliver palliative care for patients with management in decompensated cirrhosis	5
Hepatic “pregnancy”: hepatocellular carcinoma with extensive extrahepatic growth	5
Comparative analysis of analgesic efficacy and functional recovery in open pancreaticoduodenectomy: a randomized controlled trial of local anesthetic wound infiltration, transversus abdominis plane bl	5
Portal hypertensive biliopathy secondary to Abernethy malformation mimicking a hepatic hilum mass	4
Optimizing venous outflow reconstruction for V5 & V8 in right-lobe living-donor liver transplantation: “half-circumferential anastomosis” using autologous vein grafts	4
Obesity and its influence on liver dysfunction, morbidity and mortality after liver resection	4
Associations between metabolic dysfunction-associated steatotic liver disease and adverse clinical outcomes in chronic kidney disease: a prospective cohort study	4
Beyond precision: why time and human judgment still matter in the era of autonomous surgery	4
Living donor liver transplantation for Barcelona clinic liver cancer (BCLC) intermediate-stage hepatocellular carcinoma	4
Importance of an appropriate number of examined lymph nodes in patients with pancreatic cancer—the more the better?	4
Atezolizumab plus bevacizumab for patients with Child-Pugh-B in hepatocellular carcinoma	4
Improving patient stratification and selection for curative-intent treatment in localized pancreatic cancer	4
Impact of preoperative chemotherapy on surgical results in 139 patients with locally advanced pancreatic cancer	4
Lean individuals with nonalcoholic fatty liver disease, the chicken or the egg?	4
The global burden of fatty liver disease: the major impact of China	4
Predictive model for very early recurrence of patients with perihilar cholangiocarcinoma: a machine learning approach	4
A machine learning model for colorectal liver metastasis post-hepatectomy prognostications: several strategies for the model evaluation	4
Sex and age differences in the association between obesity and long-term changes with the risk of incident type 2 diabetes mellitus: the Rural Deqing Cohort Study	4
Neoadjuvant radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a systematic review	4
Insights on liver-directed surgical innovations, targeted therapies, and immunotherapy for biliary tract cancer: navigating the new European Society for Medical Oncology (ESMO) Clinical Practice Guide	4
An intriguing case of macrolides-induced pancreatic injury mimicking pancreatic carcinoma	4
Exocrine pancreatic insufficiency: more compromise than precision	4
The impact of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) on liver tumors with unusual indications	4
Short- and long-term outcomes and cost-effectiveness of robotic-assisted versus laparoscopic liver resection for Barcelona Clinic Liver Cancer (BCLC) 0/A hepatocellular carcinoma: a multicenter propen	4
Machine learning-enhanced radiomics for predicting portal vein thrombectomy in liver transplantation	4
Ascites and complications: getting to the root of the trouble	4
Liver venous deprivation (LVD) before extended hepatectomy: a French multicentric retrospective cohort	4
Hepatic metastases in ovarian cancer	4
Robotic pancreaticoduodenectomy after the learning curve—a new hope	4

Standardization is needed in reporting risk and outcomes of machine perfusion in liver transplantation	4
Beyond chemotherapy in biliary tract cancer: a closer look at the updated long-term follow-up data of the TOPAZ-1 trial	4
The difficulty of medical decision-making: should patients be involved?	4
Intestinal autotransplantation: the next level of complexity in locally advanced pancreatic cancer	4
Biliary sphincterotomy for sphincter of Oddi disorder: is sphincterotomy cutting it?	4
Surgical techniques and tumor dissemination: a critical review of the CETUPANC trial on the superior mesenteric artery vs. no-touch approaches	3
Torsion of accessory liver lobe	3
Is immunotherapy-related liver injury more common in patients with hepatocellular carcinoma than in other advanced solid tumors?	3
Advances in minimally invasive liver surgery: comparing robotic and laparoscopic approaches	3
A journey of a thousand miles begins with one small step	3
Liver anatomy by Francis Glisson	3
Incomplete ablation vs. complete ablation for solitary hepatocellular carcinoma ≤5 cm: the 10-year survival analysis	3
Time to say goodbye: from Barcelona to Milan and the modern management of hepatocellular carcinoma	3
Definition, risk factors, and outcomes of early and late recurrence after curative resection for intrahepatic cholangiocarcinoma	3
Epigenome-wide development and validation of a prognostic methylation score in intrahepatic cholangiocarcinoma based on machine learning strategies	3
Robotic-assisted cholecystectomy: stepping stone to expertise or vogue?	3
Claude Bernard’s concept of sugar metabolism in the liver	3
Alternatives to left lateral segment for pediatric liver transplantation, or required surgeon toolkit?	3
Surgical treatment strategies for multifocal hepatocellular carcinomas	3
Advanced nonmetastatic hepatocellular carcinoma: curative surgery may be an option	3
Assessing the financial and equity implications of the 2020 liver allocation policy change	3
Anatomical study of the paracaval branch of the caudate lobe: implications of paracaval portion-preserving right hepatectomy for donors with marginal remnant liver volume	3
The vascular endothelial growth factor system—a new player in the pathogenesis and development of metabolic dysfunction- associated steatotic liver disease	3
Long- and short-term outcomes for resectable gallbladder carcinoma patients treated with curative-intent laparoscopic versus open resection: a multicenter propensity score-matched comparative study	3
Assessment of morbidity and mortality after liver transplantation for primary sclerosing cholangitis	3
High risk of thrombosis recurrence in people with idiopathic or only locally caused non-cirrhotic splanchnic vein thrombosis: it is time for guidelines’ revision	3
Choledochoscopic photodynamic therapy combined with biliary stent implantation for the treatment of unresectable hilar cholangiocarcinoma	3
Advances and controversies in the management of acute cholecystitis in high-risk, critically ill, and unfit-for-surgery patients: the Italian Society of Emergency Surgery and Trauma guidelines	3
Independent risk factors for clinically relevant postoperative pancreatic fistula after robotic pancreatoduodenectomy: the protective role of the modified Blumgart pancreatojejunostomy in a single sur	3
Body mass index and ampulla of Vater cancer incidence and survival: a cohort study of 1.7 million Norwegians	3
Giant accessory hepatic lobe accompanied by inflammatory pseudotumor	3
Specific metabolic impairments indicate loss of sustained liver improvements in metabolic dysfunction-associated steatotic liver disease treatment	3
The gut-liver axis: connecting carotenoids to non-alcoholic fatty liver disease prevention—a promising pathway for future research	3
Guidelines towards comprehensive care in acute pancreatitis	3
From algorithms to adaptive frameworks: from square to circle in hepatocellular carcinoma management	3
Quest for an accurate and reproducible prognostic biomarker of severe acute pancreatitis: have we finally found it?	3
Pancreatic carcinoma disguised as type 1 autoimmune pancreatitis with a mass-forming appearance: a clinical dilemma	3
Pancreatic cancer screening in high-risk individuals with genetic susceptibility	3
A European expert consensus surgical technique description for robotic hepatectomy	3
Is liver resection necessary for T2 gallbladder cancer?	3
Application of liver transplant techniques in complex liver surgery: modified techniques and preliminary results of complex liver resection using in-situ hypothermic portal perfusion without venovenou	3
Impact of adjuvant therapy on survival outcomes in resected gallbladder cancer: a systematic review and meta-analysis	3
“PUMC’s Three Treasures”: can their glory remain?	3
Modern surgical approach to hepatocellular carcinoma	3
In memoriam of Prof. Joseph Wan-yee Lau—our distinguished senior editorial board member	3
The burden and forecasts for metabolic dysfunction-associated fatty liver disease among adolescents and young adults in the Arab region	3
Utility of liver resection for breast cancer liver metastases, time for action	3
Novel application of Yttrium-90 microsphere selective internal radiation therapy in hepatic metastases of primary fallopian tube carcinoma	3
First reported post-transplant lymphoproliferative disorder after combined heart-liver transplantation	3
Modified T category for early-staged intrahepatic cholangiocarcinoma: inclusion of perineural invasion	3
New developments in ablation therapy for hepatocellular carcinoma: combination with systemic therapy and radiotherapy	3